Halozyme Therapeutics shares owned by Arrowpoint Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Arrowpoint Asset Management
from 13F filings
Historical chart of Arrowpoint Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Arrowpoint Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Arrowpoint Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $68M | 925k | 73.34 |
| 2025-06-30 | $45M | 867k | 52.02 |
| 2025-03-31 | $87M | 1.4M | 63.81 |
| 2024-12-31 | $72M | 1.5M | 47.81 |
| 2024-09-30 | $115M | 2.0M | 57.24 |
| 2024-06-30 | $110M | 2.1M | 52.36 |
| 2024-03-31 | $76M | 1.9M | 40.68 |
| 2023-12-31 | $58M | 1.6M | 36.96 |
| 2023-09-30 | $58M | 1.5M | 38.20 |
| 2023-06-30 | $48M | 1.3M | 36.07 |
| 2023-03-31 | $44M | 1.2M | 38.19 |
| 2014-06-30 | $198k | 20k | 9.90 |
| 2014-03-31 | $446k | 35k | 12.72 |
| 2013-12-31 | $465k | 31k | 15.00 |
| 2013-09-30 | $185k | 17k | 11.04 |
More positions owned by Arrowpoint Asset Management
View all positions for Arrowpoint Asset Management